End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-14 pm EDT
|
5-day change
|
1st Jan Change
|
7.65
CNY
|
-0.13%
|
|
+0.13%
|
-10.32%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,947
|
1,941
|
2,103
|
3,880
|
2,916
|
2,919
|
Enterprise Value (EV)
1 |
1,619
|
1,582
|
1,713
|
3,332
|
2,496
|
2,514
|
P/E ratio
|
31.6
x
|
44.9
x
|
22
x
|
62.9
x
|
8.16
x
|
28.4
x
|
Yield
|
0.72%
|
1.48%
|
2.79%
|
1.1%
|
2.52%
|
-
|
Capitalization / Revenue
|
2.47
x
|
1.91
x
|
1.68
x
|
2.21
x
|
1.8
x
|
1.96
x
|
EV / Revenue
|
2.05
x
|
1.56
x
|
1.37
x
|
1.89
x
|
1.54
x
|
1.69
x
|
EV / EBITDA
|
24.8
x
|
23.6
x
|
10.6
x
|
24.1
x
|
21
x
|
21.1
x
|
EV / FCF
|
-95.3
x
|
9.03
x
|
-272
x
|
-46.8
x
|
-26.2
x
|
204
x
|
FCF Yield
|
-1.05%
|
11.1%
|
-0.37%
|
-2.14%
|
-3.82%
|
0.49%
|
Price to Book
|
3.13
x
|
2.76
x
|
2.67
x
|
3.68
x
|
2.12
x
|
-
|
Nbr of stocks (in thousands)
|
274,890
|
282,423
|
287,937
|
335,862
|
342,444
|
342,209
|
Reference price
2 |
7.083
|
6.874
|
7.303
|
11.55
|
8.516
|
8.530
|
Announcement Date
|
1/31/19
|
4/13/20
|
3/22/21
|
4/18/22
|
4/24/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
788.5
|
1,017
|
1,254
|
1,759
|
1,618
|
1,487
|
EBITDA
1 |
65.35
|
67.02
|
160.9
|
138.3
|
119
|
119.2
|
EBIT
1 |
49.37
|
44.99
|
125.6
|
101.1
|
81.85
|
74.09
|
Operating Margin
|
6.26%
|
4.42%
|
10.02%
|
5.75%
|
5.06%
|
4.98%
|
Earnings before Tax (EBT)
1 |
68.31
|
48.14
|
126.2
|
92.59
|
424.5
|
102.5
|
Net income
1 |
61.99
|
42.42
|
95.8
|
61.66
|
352
|
100.2
|
Net margin
|
7.86%
|
4.17%
|
7.64%
|
3.51%
|
21.75%
|
6.74%
|
EPS
2 |
0.2245
|
0.1531
|
0.3317
|
0.1837
|
1.043
|
0.3000
|
Free Cash Flow
1 |
-16.99
|
175.2
|
-6.292
|
-71.18
|
-95.32
|
12.32
|
FCF margin
|
-2.16%
|
17.22%
|
-0.5%
|
-4.05%
|
-5.89%
|
0.83%
|
FCF Conversion (EBITDA)
|
-
|
261.39%
|
-
|
-
|
-
|
10.33%
|
FCF Conversion (Net income)
|
-
|
412.99%
|
-
|
-
|
-
|
12.29%
|
Dividend per Share
2 |
0.0510
|
0.1019
|
0.2041
|
0.1276
|
0.2142
|
-
|
Announcement Date
|
1/31/19
|
4/13/20
|
3/22/21
|
4/18/22
|
4/24/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
328
|
359
|
390
|
549
|
420
|
405
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-17
|
175
|
-6.29
|
-71.2
|
-95.3
|
12.3
|
ROE (net income / shareholders' equity)
|
10.4%
|
6.52%
|
13.7%
|
8.79%
|
28.6%
|
6.88%
|
ROA (Net income/ Total Assets)
|
3.88%
|
2.92%
|
6.81%
|
4.26%
|
2.76%
|
2.12%
|
Assets
1 |
1,599
|
1,451
|
1,406
|
1,446
|
12,776
|
4,716
|
Book Value Per Share
2 |
2.260
|
2.490
|
2.740
|
3.140
|
4.020
|
-
|
Cash Flow per Share
2 |
0.5100
|
0.7900
|
0.8400
|
1.550
|
1.330
|
-
|
Capex
1 |
70.6
|
49.2
|
109
|
153
|
251
|
147
|
Capex / Sales
|
8.95%
|
4.84%
|
8.73%
|
8.69%
|
15.53%
|
9.87%
|
Announcement Date
|
1/31/19
|
4/13/20
|
3/22/21
|
4/18/22
|
4/24/23
|
4/22/24
|
|
1st Jan change
|
Capi.
|
---|
| -10.32% | 360M | | +5.79% | 106B | | -3.11% | 63.67B | | +73.81% | 49.32B | | +15.46% | 38.56B | | +5.46% | 32.65B | | +11.59% | 20.08B | | +13.74% | 17.01B | | +20.05% | 15.41B | | +5.02% | 14.41B |
Other Commodity Chemicals
|